Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Atai Life Sciences and Beckley Psytech Receive Breakthrough Therapy Designation for BPL-003 in Treatment-Resistant Depression

Friday, October 17, 2025

Atai Life Sciences and Beckley Psytech have announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to BPL an intranasal formulation of mebufotenin benzoate for the treatment of adults with treatmentres...

EVOQ Therapeutics Enters into Collaboration with Sanofi to Advance NanoDisc Technology for Autoimmune Disease Treatments

Friday, October 17, 2025

EVOQ Therapeutics has entered into a Collaboration and Licence Agreement with Sanofi The partnership focuses on advancing EVOQs proprietary NanoDisc technology which aims to restore the bodys natural immune tolerance mechanisms

Biocon Biologics and Civica Strengthen Collaboration to Launch Private-Label Insulin Glargine in the United States

Friday, October 17, 2025

Biocon Biologics has expanded its partnership with Civica Inc to introduce a new privatelabel Insulin Glargine medicine in the United StatesInsulin Glargineyfgn injection is indicated for improving glycaemic control in adults

Avantor and BlueWhale Bio Partner to Advance CAR-T Manufacturing with Innovative Cell Activation and Expansion Technology

Thursday, October 16, 2025

Avantor has entered into a strategic partnership with BlueWhale BioThe collaboration aims to overcome key challenges in CART production including variability high costs and lengthy processing times

Viatris Completes Acquisition of Aculys Pharma for Rights to Pitolisant and Spydia® in Japan and Asia-Pacific Markets

Thursday, October 16, 2025

Viatris has completed the acquisition of Aculys PharmaThe acquisition grants Viatris exclusive rights to develop and commercialise pitolisant and Spydia strengthening its Central Nervous System CNS portfolio in Japan and selected AsiaPacific markets

Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

Thursday, October 16, 2025

Minovia Therapeutics has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for its investigational therapy MNV in Myelodysplastic Syndrome MDS

Nabla Bio Enters into Collaboration with Takeda to Advance AI-Based Protein Therapeutics Design

Wednesday, October 15, 2025

Nabla Bio has entered into a new multiyear research partnership with Takeda to enhance the design of protein therapeutics Under the agreement Nabla Bio will receive payments in the doubledigit millions as upfront and research funding with the potenti...

Mabwell’s CDH17-Targeting ADC 7MW4911 Receives IND Clearance from NMPA

Wednesday, October 15, 2025

Mabwell has received Investigational New Drug IND clearance from the National Medical Products Administration NMPA in China for its CDHtargeting antibodydrug conjugate ADC MW